Promoter Bank clone, Human collagenase-1 (MMP-1) promoter
Alternative name | p1886-2F |
---|---|
Clone info. | PCR amplified human collagenase-1 (MMP-1) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Cloned fragment: 102800490 to 102798158 (NC_000011.10); relatively -2255 to +78, where +1 corresponds to 1nt of NM_002421.3. |
Comment | PCR cloning, forward primer, 1886 F1: 5' gtttccaatccacgtcagcaact 3'; reverse primer, F2PB0014R: 5' tatcccagctaggaagctccctctg 3' Known differences with NC_000011.10: A to G substitution at 102,798,479 and T to C substitution at 102,800,447. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pKM2L (RDB04026) (Plasmid) |
Size of vector backbone | 4.2 kb |
Selectable markers | Kan^r |
Gene/insert name | Human collagenase-1 (MMP-1) genomic DNA |
Depositor|Developer | DNA Bank, | |
Sequence | RDB05478z.seq |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05478 | pKM2L-phMMP1 | DNA solution |
Materials & Methods section:
The pKM2L-phMMP1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05478). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB17373_A9Fap1-2.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 () Sequence file: RDB17373_A9Faa.seq |
---|
>05478_17373_A9Fa_1_M13_-40_E07_05_ABI08.ab1 1 AGCCCAGGGG CAAGCTTGCA TGCCTGCAGG TCATTTAAAT AGGGATAACA GGGTAATGAT 61 TAAGATCTCG AGCTCTAAGC TTCACATATG CATGCACTAG TGGCGTTTCC AATCCACGTC 121 AGCAACTATG ACATTTAATG AAACACTGTG AGCATTTAGC ATGAGAGCTC TGGACTCAGA 181 TGCAGGGAGC TTTGCTAGAG AAGGGAGGAA AAAGCAGGCA TGATGTGGCG GGTTGTGGGG 241 GACTCCAAGG CTCTATTTCC AACTTCCATC AGAGAACTTC TGTTTTCACC TGGTTTTCAA 301 ATTTGCTTTC CAAAAGGGAT TTTGTTTAAG TAAAGGATAC AGAGGTTTAT AAAAGTTTGA 361 AAACTTCTAC ATTGCAGGAT GTGCAGGCTC TTGCCAGATG GGACAGTGTA TGAGACTCTT 421 CCAGGGTGAC GTCTTAGGCA ATTTCCTGTC CAATCACAGA TGGTCACATG CTGCTTTCCT 481 GAGTTAACCT ATTAACTCAC CCTTGTTTCC CAGGCCTCAG TGGAGCTAGG CTTGTCACGT 541 CTTCACAGTG ACTAGATTCC CTCACAGTCG AGTATATCTG CCACTCCTTG ACTTTTAAAA 601 CATAGTCTAT GTTCACCCTC TAATATGAAG AGCCCCTTTC ACTATTTTCT TTGTCTGTGC 661 TGGAATCACT TCCAGGGCAA GTTGTCCTTG GTCTTCGCCC CACCCTCCCT CTGAATGCTC 721 TGAGAAGAAG AATTCCTTTT CCTTAAAAAG GCTTCCCCAT CCTCCTACCC TCCTGAACTC 781 ACATGGTATG CCACTTAAAT GAAGAAATTG GAGTTAAATA ATTAGAAAAG ATATGAATTA 841 ACTCCAATCC ATTCAAGATA TTCTTAAGTA TTGTTTATGA ATTAGATATC CGTCCTGACG 901 CCGAAAGAAA ACCAGGATTC ATAAGGGGAA GAAAGTGGTT GAAAGCAACC CGATACGTGG 961 GGAAAGGGGG GAGACACCCT AAGGGCTGAA GTGATAAAAA AGGCCAGTGG TTCCTTCACG 1021 TATTGGTTTT TCAATAAATG CTTTCCCAAG GGAAGGGGAG ATGGGCCATG AAGTAGGGGA 1081 GCTACACGAG AGATAACCAA CCTTTCTTTA CCAAGGAATG CTACAGATAG CACTTGGTGA 1141 CACCCTGGTT CACCATGTAC CCAGACCAAT TATAATGTGT GGGAACACTT AAGACGTTCT 1201 ACAC // |
Primer: phRLR2 () Sequence file: RDB17373_A9Fab.seq |
>05478_17373_A9Fa_1_phRLR2_F07_06_ABI08.ab1 1 ATTCTTGGTC TCGAACAGCC CAGTTTCTAT TGGTCTCCTT AAACCTGTCT TGTAACCTTG 61 ATACTTACCT GCCCAGTGCC TCACGACCAA CTTCTGCAGT ACCCGGGTGA ATTCTACGCG 121 TCGACAGGCT ATCCCAGCTA GGAAGCTCCC TCTGTATATA TAGAGTCCTT GCCCTTCCAG 181 AAAGCCAGAG GCTGTCTGAC TCATGCTTTA TAACATCCTC TTGATTAGCT ATGAATAGAC 241 TAGGCAATCA TTAGAAATGG TGACTCCTAG CAGATTATTT GGAATCACTT GGTGTTGCAA 301 TGTCATGATT AACTTCAAAC AAGATGTGTG CGAAGGAGAC ACACTCTGCC ATGTAAACAG 361 TGGTTTTCTC CAATTCATTT CTTTCCTATT TGAGAAAGGT TCTTGTTATA TACACAGGTC 421 AAAGAGTACT CCATGGTCTT TTTGAAAAAG GCTGGTTCTG ATGGTCATAA AGTGCTACAG 481 GTTTCTCCAC ACACCTTGCT CCCAGGGCAG AGGGTGGAAT TACTAACACT GCGCACCTGA 541 TGGCTGTTCG GCACCTGTAC TGACTGAAGT TCAGCTCCCC CAGCACTCAC TTTACGGTGG 601 CTCTTCGGGG TTCTCTGAGG TTCCCTTCTG CCTTTGTTAA GCTGCCTGGT ACCCTATTGC 661 GATAGCACCA TGGCTTCCCT TAATCTTTAC TCAGAGCCAG GCATGGTGGC TCAAGCCTAT 721 AATCCCAGAA TTTCAGGAGG CCGAGGCAGG GGAATCACTT GAGCCCAGGA GTTCAAGATC 781 AGCCTGGGCA ACATGGTGAG ACCCCATCTC TGTAAAAAAC AAACAAACAA ACAAACATTT 841 TTTAAAGTTA GCCAAGCATG GAGTCATGCA CCTGTAGTCC TAGTCACTGA AGAGGCTGAG 901 TGGGAGGATC ACTTGGGCCT GGGGAGGTTG AGGCTGCATT GAGCTGTGAT TGTGCCGCTG 961 CACTCCAGCC TAGCACAGAG AGGGACCCTG TCTAAATAAA TTTGAAAAAA ATTTACTCAG 1021 GCCTAGGATT AAGAGCCTTT ACCTGAAGAA GACCCCCTCA TCCACAAGCC GGAGTATGAG 1081 ATACCTCCCC CACCCCCTTT GCCCATCATT ATCATGGGAC AAATAGGGAA TCTTCCTGGA 1141 ACTGTTCTGA AATGTAACCG ATGAATGAAA AGGGCTGGAA AGGAACTGAA CGGTAAACTC 1201 TGGAGACTCG TAGAT // |
Primer: pAxCALNL_F1 () Sequence file: RDB17373_A9Fac.seq |
>05478_17373_A9Fa_1_pAxCALNL_F1_G07_07_ABI08.ab1 1 CACCAGGTAT CTTATCATGT CTGCTCGAAG CGGCCGCTCT AGAATTACTG CTCGTTCTTC 61 AGCACGCGCT CCACGAAGCT CTTGATGTAC TTACCCATTT CATCTGGAGC GTCCTCCTGG 121 CTGAAGTGGA GGCCCTTCAC CTTCACGAAC TCGGTGTTAG GGAACTTCTT AGCTCCCTCG 181 ACAATAGCGT TGGAAAAGAA CCCAGGGTCG GACTCGATGA ACATCTTAGG CAGATCGTCG 241 CTGGCCCGAA GGTAGGCGTT GTAGTTGCGG ACAATCTGGA CGACGTCGGG CTTGCCTCCC 301 TTAACGAGAG GGATCTCGCG AGGCCAGGAG AGGGTAGGCC GTCTAACCTC GCCCTTCTCC 361 TTGAATGGCT CCAGGTAGGC AGCGAACTCC TCAGGCTCCA GTTTCCGCAT GATCTTGCTT 421 GGGAGCATGG TCTCGACGAA GAAGTTATTC TCAAGCACCA TTTTCTCGCC CTCTTCGCTC 481 TTGATCAGGG CGATATCCTC CTCGATGTCA GGCCACTCGT CCCAGGACTC GATCACGTCC 541 ACGACACTCT CAGCATGGAC GATGGCCTTG ATCTTGTCTT GGTGCTCGTA GGAGTAGTGA 601 AAGGCCAGAC AAGCCCCCCA GTCGTGGCCC ACAAAGATGA TTTTCTTTGG AAGGTTCAGC 661 AGCTCGAACC AAGCGGTGAG GTACTTGTAG TGATCCAGGA GGCGATATGA GCCATTCCCG 721 CTCTTGCCGG ACTTACCCAT TCCGATCAGA TCAGGGATGA TGCATCTAGC CACGGGCTCG 781 ATGTGAGGCA CGACGTGCCT CCACAGGTAG CTGGAGGCAG CGTTACCATG CAGAAAAATC 841 ACGGCGTTCT CGGCGTGCTT CTCGGAATCA TAGTAGTTGA TGAAGGAGTC CAGCACGTTC 901 ATTTGCTTGC AGCGAGCCCA CCACTGAGGC CCAGTGATCA TGCGTTTGCG TTGCTCGGGG 961 TCGTACACCT TGGAAGCCAT GGTGGCTAGC CTATAGTGAG TCGTATTAAG TACTCTAGCC 1021 CTTAAGAGCT GTAATTGAAC TGGGAGTGGA CACCTGTGGA GGAGAAAGGC AAAGTGGATG 1081 TCAGTTAAGA TAATAGGTGC TTATCAGAAA CGCAGAGTCT CTCTGGTTTC GACAGGCCCA 1141 GTTTCTATTG GATCTCGTTT AAACTGTGTC TTTGGTTAAC CT // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content